Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,087 Dermatology
clinical trials

Chronic Hand Dermatitis Clinical Trial
Apremilast and Moderate to Severe Chronic Hand Dermatitis
Status: Upcoming, Phase IV
Updated: 12/31/1969
George Washington University Department of Dermatology
mi
from
Washington DC,
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Ophthalmology Clinical Trial
Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders
Status: Upcoming, Phase III
Updated: 12/31/1969
Center for Sight
mi
from
Sacramento, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling, Phase III
Updated: 4/18/2014
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
CrescentCare Health
mi
from
New Orleans, LA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Other Clinical Trial
Pilot Tape Harvesting Study
Status: Enrolling
Updated: 3/25/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling, Phase II
Updated: 2/29/2016
Clinical Research Facility
mi
from
Sanford, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 52
mi
from
Macon, GA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling, Phase II
Updated: 1/21/2016
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Keratoconus Clinical Trial
McNeel Eye Center Corneal Crosslinking Study
Status: Enrolling
Updated: 12/31/1969
McNeel Eye Center
mi
from
Boise, ID
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Ophthalmology Clinical Trial
COLLAGEN CROSS-LINKING WITH ULTRAVIOLET-A IN ASYMMETRIC CORNEAS
Status: Enrolling, Phase II
Updated: 12/31/1969
Ophthalmology Associates
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
Status: Enrolling
Updated: 12/31/1969
The Canterbury
mi
from
Rancho Palos Verdes, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regeneron Study Site
mi
from
Lebanon, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Cummins, Kozak, Gillman & Ellis, Inc
mi
from
Orange, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Pace Dermatology Associates
mi
from
Lakewood, WA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Australian Clinical Research Network
mi
from
Maroubra,
Click here to add this to my saved trials
Ichthyosis Vulgaris Clinical Trial
A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris
Status: Enrolling, Phase II
Updated: 12/31/1969
Crown investigative site 01
mi
from
San Diego, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases Clinical Trial
Defining the Skin and Blood Biomarkers of Ichthyosis
Status: Enrolling, Phase
Updated: 12/31/1969
Northbrook Lurie Children's Outpatient Clinic
mi
from
Chicago, IL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
MUSC SCTR Research Nexus Clinic and Laboratory
mi
from
Charleston, SC
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Allergy & Asthma Associates of Southern California dba Southern California Research
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
NorthShore University HealthSystem Dermatology Clinical Trials Unit
mi
from
Skokie, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bellaire Dermatology
mi
from
Bellaire, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bexley Dermatology Research
mi
from
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology and Skin Cancer Specialists
mi
from
Rockville, MD
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research-Walnut Creek
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Progressive Keratoconus Clinical Trial
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolina Cataract & Laser Center
mi
from
Ladson, SC
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Timber Lane Allergy and Asthma Research, LLC
mi
from
Burlington, VT
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Asthma, Nasal Disease, and Allergy Research Center of New England
mi
from
East Providence, RI
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
San Tan Allergy & Asthma
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southern California Research Center
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Urticaria Clinical Trial
Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)
Status: Enrolling, Phase II
Updated: 12/31/1969
Vital Prospects Clinical Research Institute PC - CRN
mi
from
Tulsa, OK
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Ophthalmology Clinical Trial
Corneal Elastography and Patient Specific Modeling
Status: Enrolling
Updated: 1/26/2018
Cleveland Clinic Foundation; Cole Eye Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Research Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational site
mi
from
Plainfield, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 520
mi
from
Bellaire, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 201
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 526
mi
from
Henderson, NV
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 383
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 359
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 112
mi
from
Tulsa, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
Institute of Skin Advancement Medical, Surgical, Costmetic & Laser Dermatology
mi
from
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
DermDox Centers for Dermatology
mi
from
Hazleton, PA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 501
mi
from
Aventura, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 510
mi
from
Newnan, GA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 222
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study of Adult Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
Status: Enrolling, Phase
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Moderate to Severe Atopic Dermatitis Clinical Trial
Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Glenmark Investigational Site 15
mi
from
Tampa, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Research Center, Inc. - Los Alamitos Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bellaire Dermatology
mi
from
Bellaire, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bexley Dermatology Research
mi
from
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology and Skin Cancer Specialists
mi
from
Rockville, MD
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research-Walnut Creek
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Encinitas, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
North Charleston, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
1 … 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21